Familial emphysema, also known as alpha-1 antitrypsin deficiency (AATD), is a genetic condition that affects the lungs and liver. Here's an overview of its symptoms, diagnosis, testing, and treatment.
Respiratory Symptoms:
Shortness of breath, especially during physical activity
Wheezing
Chronic cough
Recurring respiratory infections
Barrel-shaped chest due to lung hyperinflation
Liver Symptoms:
Jaundice (yellowing of the skin and eyes)
Enlarged liver or spleen
Abdominal swelling or pain
Elevated liver enzymes
Symptomatic Management:
Bronchodilators to relieve airway constriction and improve breathing.
Inhaled corticosteroids to reduce inflammation in the airways.
Antibiotics for treating respiratory infections.
Oxygen therapy for advanced cases to alleviate hypoxemia.
Augmentation Therapy:
Infusion of purified alpha-1 antitrypsin protein derived from human plasma.
This therapy aims to raise AAT levels in the blood and protect the lungs from damage.
Pulmonary Rehabilitation:
Exercise programs to improve lung function and overall physical conditioning.
Nutritional counseling to maintain a healthy weight and support respiratory health.
Liver Disease Management:
Management of liver complications, such as cirrhosis or liver failure, if present.
Liver transplant may be considered in severe cases of liver disease.
Smoking Cessation:
Avoidance of smoking and exposure to environmental pollutants to prevent further lung damage.
Genetic Counseling:
Counseling for affected individuals and their families regarding the inheritance pattern and risk of passing the condition to future generations.
Blood Tests:
Measurement of alpha-1 antitrypsin (AAT) levels in the blood.
Genetic testing to identify mutations in the SERPINA1 gene, which encodes AAT.
Lung Function Tests:
Pulmonary function tests (PFTs) to assess lung capacity, airflow, and gas exchange.
Chest X-rays or CT scans to visualize lung damage.
Liver Function Tests:
Blood tests to measure liver enzyme levels and assess liver function.